SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009344
Filing Date
2022-05-11
Accepted
2022-05-11 16:16:24
Documents
71
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q svra-20220331.htm   iXBRL 10-Q 1696944
2 EX-10.1 svra-ex10_1.htm EX-10.1 654663
3 EX-31.1 svra-ex31_1.htm EX-31.1 18181
4 EX-31.2 svra-ex31_2.htm EX-31.2 18159
5 EX-32.1 svra-ex32_1.htm EX-32.1 12793
6 GRAPHIC img197164346_0.jpg GRAPHIC 3968
  Complete submission text file 0000950170-22-009344.txt   8151763

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT svra-20220331.xsd EX-101.SCH 60974
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT svra-20220331_cal.xml EX-101.CAL 43790
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT svra-20220331_def.xml EX-101.DEF 179463
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT svra-20220331_pre.xml EX-101.PRE 304342
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT svra-20220331_lab.xml EX-101.LAB 423556
65 EXTRACTED XBRL INSTANCE DOCUMENT svra-20220331_htm.xml XML 1474779
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 22913928
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences